These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 3942053)
1. Survivors of cardiac arrest: prevention of recurrence by drug therapy as predicted by electrophysiologic testing or electrocardiographic monitoring. Skale BT; Miles WM; Heger JJ; Zipes DP; Prystowsky EN Am J Cardiol; 1986 Jan; 57(1):113-9. PubMed ID: 3942053 [TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study. Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357 [TBL] [Abstract][Full Text] [Related]
3. Out-of-hospital cardiac arrest in patients with no overt heart disease: electrophysiologic observations and clinical outcome. Bhandari AK; Hong R; Au P; McKay CR; Rahimtoola SH Can J Cardiol; 1988 Mar; 4(2):80-4. PubMed ID: 3365601 [TBL] [Abstract][Full Text] [Related]
4. [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation]. Raviele A; Di Pede F; Delise P; Piccolo E G Ital Cardiol; 1984 Sep; 14(9):644-54. PubMed ID: 6510619 [TBL] [Abstract][Full Text] [Related]
5. Nonsustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study. Buxton AE; Marchlinski FE; Flores BT; Miller JM; Doherty JU; Josephson ME Circulation; 1987 Jun; 75(6):1178-85. PubMed ID: 3568327 [TBL] [Abstract][Full Text] [Related]
6. Value of serial electropharmacological testing in managing patients resuscitated from cardiac arrest. Raviele A; Di Pede F; Delise P; Piccolo E Pacing Clin Electrophysiol; 1984 Sep; 7(5):850-60. PubMed ID: 6207498 [TBL] [Abstract][Full Text] [Related]
7. Predictors of efficacy of amiodarone and characteristics of recurrence of arrhythmia in patients with sustained ventricular tachycardia and coronary artery disease. Zhu J; Haines DE; Lerman BB; DiMarco JP Circulation; 1987 Oct; 76(4):802-9. PubMed ID: 3652422 [TBL] [Abstract][Full Text] [Related]
8. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. Mason JW N Engl J Med; 1993 Aug; 329(7):445-51. PubMed ID: 8332149 [TBL] [Abstract][Full Text] [Related]
9. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study. Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444 [TBL] [Abstract][Full Text] [Related]
10. Electrophysiologic studies before and after myocardial revascularization in patients with life-threatening ventricular arrhythmias. Garan H; Ruskin JN; DiMarco JP; Derkac WM; Akins CW; Daggett WM; Austen WG; Buckley MJ Am J Cardiol; 1983 Feb; 51(3):519-24. PubMed ID: 6600577 [TBL] [Abstract][Full Text] [Related]
11. Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrest. Morady F; Scheinman MM; Hess DS; Sung RJ; Shen E; Shapiro W Am J Cardiol; 1983 Jan; 51(1):85-9. PubMed ID: 6849269 [TBL] [Abstract][Full Text] [Related]
12. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs. Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926 [TBL] [Abstract][Full Text] [Related]
13. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia. Veltri EP; Reid PR; Platia EV; Griffith LS Am J Cardiol; 1985 Feb; 55(4):375-9. PubMed ID: 3969872 [TBL] [Abstract][Full Text] [Related]
14. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring]. Tsuchiya M; Kasanuki H; Ohnishi S; Hosoda S J Cardiol; 1996 Nov; 28(5):267-76. PubMed ID: 8953400 [TBL] [Abstract][Full Text] [Related]
15. Results of electrophysiologic testing and long-term prognosis in patients with coronary artery disease and aborted sudden death. Sousa J; Rosenheck S; Calkins H; de Buitleir M; Schmaltz S; Kadish A; Morady F Am Heart J; 1991 Oct; 122(4 Pt 1):1001-6. PubMed ID: 1927851 [TBL] [Abstract][Full Text] [Related]
16. Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (the CASCADE study). Am J Cardiol; 1991 Mar; 67(7):578-84. PubMed ID: 2000790 [TBL] [Abstract][Full Text] [Related]
17. Amiodarone: correlation of early and late electrophysiologic studies with outcome. Kadish AH; Marchlinski FE; Josephson ME; Buxton AE Am Heart J; 1986 Dec; 112(6):1134-40. PubMed ID: 3788759 [TBL] [Abstract][Full Text] [Related]
18. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone. McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300 [TBL] [Abstract][Full Text] [Related]
19. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia. Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883 [TBL] [Abstract][Full Text] [Related]
20. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators. Am J Cardiol; 1993 Aug; 72(3):280-7. PubMed ID: 8342505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]